Please try another search
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Name | Age | Since | Title |
---|---|---|---|
Andrew Norris | - | - | Scientific Advisor |
Lachlan Thompson | - | - | Scientific Advisor |
Dwain K. Morris-Irvin | 56 | 2020 | CEO & Director |
Renard Currie | - | - | Member of the Advisory Board |
Kim Seroogy | - | 2022 | Scientific Advisor |
Jason M. Anderson | 49 | 2022 | Independent Director |
Laina King | - | - | Scientific Advisor |
Roscoe M. Moore | 78 | 2023 | Member of Scientific Advisory Board |
John A. Cassarini | 58 | 2022 | Independent Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review